F FIREBRICKPHARMA

Serial Number 79338107
Registration 7159599
700

Registration Progress

Application Filed
Mar 7, 2022
Under Examination
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
Sep 12, 2023

Trademark Image

F FIREBRICKPHARMA

Basic Information

Serial Number
79338107
Registration Number
7159599
Filing Date
March 7, 2022
Registration Date
September 12, 2023
Published for Opposition
June 27, 2023
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 12, 2023
Registration
Registered
Classes
005

Rights Holder

Firebrick Pharma Limited

82
Address
Level 10, 440 Collins Street
Melbourne VIC 3000
AU

Ownership History

Firebrick Pharma Limited

Original Applicant
82
AU

Firebrick Pharma Limited

Owner at Publication
82
AU

Firebrick Pharma Limited

Original Registrant
82
AU

Legal Representation

Attorney
Lori Kozak

USPTO Deadlines

Next Deadline
1331 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20230912)
Due Date
September 12, 2029
Grace Period Ends
March 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

41 events
Date Code Type Description Documents
Jan 2, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 13, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 13, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 12, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 12, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 12, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 25, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jun 7, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 7, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 24, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 24, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 24, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 24, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 24, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 24, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 9, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Apr 21, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 21, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 21, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 17, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 17, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 6, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Feb 15, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 15, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 21, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 20, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 17, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 19, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for the skin, nails, scalp and body for the treatment and prevention of bacterial and viral infections and diseases
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a stylized letter "F" followed by the wording "FIREBRICKPHARMA".

Classification

International Classes
005